Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Dishy

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Pharmacology|February 28, 2020
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and EnoxaparinTharin Limsakun, Victor Dishy, Jeanne Mendell, et al.
Clinical Drug Investigation|July 20, 2019
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy SubjectsYutaro Maekawa, Hidetoshi Furuie, Manabu Kato, et al.
Journal of Clinical Pharmacology|December 14, 2011
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patientsMarc L Reitman, Victor Dishy, Allison Moreau, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
Alpha 1A-adrenergic receptor polymorphism and vascular responseGbenga G Sofowora, Victor Dishy, Ruth Landau, et al.
American Journal of Therapeutics|May 13, 2009
Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiencyMark Stroh, Larissa Wenning, Wen-Lin Luo, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Circulation|November 19, 2014
Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrateHamim Zahir, Karen S Brown, Alexander G Vandell, et al.
Platelets|April 30, 2011
The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirinAimee Dallob, Wen-Lin Luo, Julie Mabalot Luk, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Pharmacology|February 28, 2020
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and EnoxaparinTharin Limsakun, Victor Dishy, Jeanne Mendell, et al.
Clinical Drug Investigation|July 20, 2019
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy SubjectsYutaro Maekawa, Hidetoshi Furuie, Manabu Kato, et al.
Journal of Clinical Pharmacology|December 14, 2011
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patientsMarc L Reitman, Victor Dishy, Allison Moreau, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
Alpha 1A-adrenergic receptor polymorphism and vascular responseGbenga G Sofowora, Victor Dishy, Ruth Landau, et al.
American Journal of Therapeutics|May 13, 2009
Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiencyMark Stroh, Larissa Wenning, Wen-Lin Luo, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Circulation|November 19, 2014
Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrateHamim Zahir, Karen S Brown, Alexander G Vandell, et al.
Platelets|April 30, 2011
The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirinAimee Dallob, Wen-Lin Luo, Julie Mabalot Luk, et al.
Pageof 4